It ishypothesized that NO signaling could contribute to therapy resistance inepithelial ovarian cancer by modulating survivin expression since low levels ofNO are associated with resistance to carboplatin- and paclitaxel-inducedapoptosis [40]. The gene discussed is BIRC5; the disease is ovarian cancer.